Clinical and translational results of CALGB 40601: A neoadjuvant phase III trial of weekly paclitaxel and trastuzumab with or without lapatinib for HER2-positive breast cancer.
暂无分享，去创建一个
D. Berry | C. Perou | E. Winer | C. Hudis | L. Carey | L. Harris | C. Anders | C. Cirrincione | D. Ollila | I. Krop | N. Henry | D. Weckstein | Alliance | N. L. Henry